Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 19 Feb 2026 for Immunocore Holdings plc, €19k.
Filing timeline
BuySaleJohn Goll
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
John Goll: trading record in brief
John Goll discloses dealings in 2 companies, chiefly INSMED Inc and Immunocore Holdings plc. Between 18 November 2019 and 18 February 2026, the trades on record add up to 6 filings.
Every open-market trade on record is a sale: 2 sales worth €472k. Besides market trades, the filings include 2 share grants and 2 option exercises. Since January 2026: no purchases and 1 sale on the market.
On 19 February 2026 came the latest disclosure, an open-market sale for €19k in Immunocore Holdings plc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John Goll
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
698 shares@ US$32.35100.0% of flowOrdinary SharesSEC:0001779466-26-000002:1
1,351 shares0Ordinary SharesSEC:0001779466-26-000002:0
5,263 sharesCommon StockSEC:0001127430-20-000023:0
208 shares@ US$23.750.6% of flowCommon StockSEC:0001127430-20-000023:1
25,000 shares@ US$12.5838.3% of flowStock OptionSEC:0001127430-19-000131:0
25,000 shares@ US$20.0461.1% of flowStock OptionSEC:0001127430-19-000131:1
6 of 6 declarations
